Event Details

Spark Therapeutics, Inc. at NEI/FDA Endpoints Workshop

Wednesday, November 9, 2016 2:05 p.m. ET  
Title
Spark Therapeutics, Inc. at NEI/FDA Endpoints Workshop
Date / Time
11/09/16 2:05 p.m. ET
Location
Lister Hill Center – NIH Campus
Bethesda MD 
Description
Albert M. Maguire, M.D., professor of ophthalmology at the Perelman School of Medicine of the University of Pennsylvania and principal investigator in the clinical trials of Spark Therapeutics’ investigational therapy voretigene neparvovec, will give a presentation entitled “Endpoints for Gene Therapy Clinical Trials – Low Luminance Mobility Maze”, on Wednesday, Nov. 9, at 2:05 p.m. EST